{"title":"Temporal wheat proteome remodeling by deoxynivalenol reveals novel detoxification signatures and strategies across cultivars.","authors":"Reid Buchanan, Kholoud Shaban, Boyan Liu, Norris Chan, Mitra Serajazari, Jennifer Geddes-McAlister","doi":"10.1016/j.mcpro.2025.100988","DOIUrl":null,"url":null,"abstract":"<p><p>Fusarium head blight (FHB) is a globally devastating fungal disease resulting in reduced grain yield and quality, along with contamination of grains with dangerous mycotoxins. Consumption of such mycotoxins by humans through processed food or livestock through feed has downstream implications for human and animal health. This interconnectivity across the environment, animal, and human health defines the One Health problem of threatened food safety and security. In this study, we explore remodeling of the wheat proteome upon exposure to a common mycotoxin, deoxynivalenol (DON). We investigate cultivar-specific responses to DON exposure in FHB-susceptible (Norwell) and -resistant (Sumai#3) cultivars across a continuum of exposure (i.e., 24 and 120 hours post inoculation), and upon low (i.e., 0.1 mg/mL) and high (1.0 mg/mL) levels of the mycotoxin. This complex experimental design enables us to tease apart the dynamic relationship between each cultivar and DON tolerance. Specifically, we define precise proteins and broad categories of remodeling that are common (i.e., reduction in photosynthesis) and exclusive (i.e., glycosyltransferase) to the cultivars and align with anticipated protective mechanisms. Moreover, we adapted an in vitro DON tolerance expression system and determined that induction of an ubiquinol oxidase (UniProt ID: A0A3B6B5K8) provides heightened protection for yeast growth relative to the negative control, as well as increased protection compared to a well-defined DON detoxifying protein. Our study suggests a new avenue for identification and characterization of novel DON detoxifying proteins as putative biomarkers for selected breeding strategies. Such strategies support the production of wheat varieties with increased tolerance to DON for improved global food safety and security.</p>","PeriodicalId":18712,"journal":{"name":"Molecular & Cellular Proteomics","volume":" ","pages":"100988"},"PeriodicalIF":6.1000,"publicationDate":"2025-05-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Molecular & Cellular Proteomics","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1016/j.mcpro.2025.100988","RegionNum":2,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"BIOCHEMICAL RESEARCH METHODS","Score":null,"Total":0}
引用次数: 0
Abstract
Fusarium head blight (FHB) is a globally devastating fungal disease resulting in reduced grain yield and quality, along with contamination of grains with dangerous mycotoxins. Consumption of such mycotoxins by humans through processed food or livestock through feed has downstream implications for human and animal health. This interconnectivity across the environment, animal, and human health defines the One Health problem of threatened food safety and security. In this study, we explore remodeling of the wheat proteome upon exposure to a common mycotoxin, deoxynivalenol (DON). We investigate cultivar-specific responses to DON exposure in FHB-susceptible (Norwell) and -resistant (Sumai#3) cultivars across a continuum of exposure (i.e., 24 and 120 hours post inoculation), and upon low (i.e., 0.1 mg/mL) and high (1.0 mg/mL) levels of the mycotoxin. This complex experimental design enables us to tease apart the dynamic relationship between each cultivar and DON tolerance. Specifically, we define precise proteins and broad categories of remodeling that are common (i.e., reduction in photosynthesis) and exclusive (i.e., glycosyltransferase) to the cultivars and align with anticipated protective mechanisms. Moreover, we adapted an in vitro DON tolerance expression system and determined that induction of an ubiquinol oxidase (UniProt ID: A0A3B6B5K8) provides heightened protection for yeast growth relative to the negative control, as well as increased protection compared to a well-defined DON detoxifying protein. Our study suggests a new avenue for identification and characterization of novel DON detoxifying proteins as putative biomarkers for selected breeding strategies. Such strategies support the production of wheat varieties with increased tolerance to DON for improved global food safety and security.
期刊介绍:
The mission of MCP is to foster the development and applications of proteomics in both basic and translational research. MCP will publish manuscripts that report significant new biological or clinical discoveries underpinned by proteomic observations across all kingdoms of life. Manuscripts must define the biological roles played by the proteins investigated or their mechanisms of action.
The journal also emphasizes articles that describe innovative new computational methods and technological advancements that will enable future discoveries. Manuscripts describing such approaches do not have to include a solution to a biological problem, but must demonstrate that the technology works as described, is reproducible and is appropriate to uncover yet unknown protein/proteome function or properties using relevant model systems or publicly available data.
Scope:
-Fundamental studies in biology, including integrative "omics" studies, that provide mechanistic insights
-Novel experimental and computational technologies
-Proteogenomic data integration and analysis that enable greater understanding of physiology and disease processes
-Pathway and network analyses of signaling that focus on the roles of post-translational modifications
-Studies of proteome dynamics and quality controls, and their roles in disease
-Studies of evolutionary processes effecting proteome dynamics, quality and regulation
-Chemical proteomics, including mechanisms of drug action
-Proteomics of the immune system and antigen presentation/recognition
-Microbiome proteomics, host-microbe and host-pathogen interactions, and their roles in health and disease
-Clinical and translational studies of human diseases
-Metabolomics to understand functional connections between genes, proteins and phenotypes